KR
KRMD
KORU Medical Systems, Inc.
$4.15
+3.75%
$183.7M
No data for this timeframe.
Vol
Market Cap$183.7M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (82%)
Inst. Holders7 funds
Inst. Value$16.7M
Inst. Activity5 buys / 0 sells
Insider Activity5B / 0S
Insider Net $$1.5M
SEC Reports5
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0000704440·Prev Close $4.00
Recent Activity
May 20, 2026
SEC
KORU Medical Systems insiders executed a concentrated buying cluster, with CEO Linda Tharby making a $1.42M open-market
CLUSTER — Impact 7/10
May 20, 2026
SEC
Three senior insiders at KORU Medical Systems — CEO, CFO, and COO — collectively purchased ~$1.46M of KRMD stock in open
CLUSTER — Impact 7/10
May 20, 2026
SEC
CEO Linda Tharby made a $1.42M open-market purchase, the largest insider buy in the cluster, representing ~0.8% of marke
CLUSTER — Impact 7/10
May 18, 2026
Insider
Schiller Eric bought 5,000 shares
Chief Technology Officer @ $3.91 ($19.6K)
May 15, 2026
Insider
Tharby Linda M bought 1,191 shares
Chief Executive Officer @ $3.92 ($4.7K)
May 15, 2026
Insider
Tharby Linda M bought 1,191 shares
Chief Executive Officer @ $1,191.00 ($1.4M)
Inst.
MORGAN STANLEY — ADD
427,026 shares ($2.5M)
Inst.
WELLS FARGO & COMPANY/MN — ADD
47,264 shares ($274.6K)
Price Targets
$6.80
+63.9% upside
Strong Buy
Current $4.15
Low $5.00
Median $7.00
High $8.00
5 analysts
$5.00
$8.00
Analyst Ratings
2Strong Buy
7Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 13, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| Mar 13, 2026 | B. Riley Securities | MAINTAIN | Buy → Buy |
| Dec 22, 2025 | Lake Street | MAINTAIN | Buy → Buy |
| Dec 17, 2025 | Canaccord Genuity | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.01 | $-0.01 — $0.00 | -150% YoY | 2 |
| Next Q | $0.01 ▼ -50.0% | $0.00 — $0.01 | 0% YoY | 2 |
| Current FY | $0.02 ▼ -33.3% | $0.01 — $0.03 | 100% YoY | 2 |
| Next FY | $0.08 ▼ -5.9% | $0.07 — $0.09 | 300% YoY | 2 |
Latest Reports
BULLISH
CLUSTER
7/10
KORU Medical Systems insiders executed a concentrated buying cluster, with CEO Linda Tharby making a $1.42M open-market
May 20, 2026
BULLISH
CLUSTER
7/10
Three senior insiders at KORU Medical Systems — CEO, CFO, and COO — collectively purchased ~$1.46M of KRMD stock in open
May 20, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $12.8M | — |
| MORGAN STANLEY | $2.5M | ADD |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $701.1K | DOUBLED |
| WELLS FARGO & COMPANY/MN | $274.6K | ADD |
| TWO SIGMA INVESTMENTS, LP | $178.0K | NEW |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 18, 2026 | Schiller Eric | BUY | $19.6K |
| May 15, 2026 | Tharby Linda | BUY | $4.7K |
| May 15, 2026 | Tharby Linda | BUY | $1.4M |
| May 14, 2026 | Adams Thomas | BUY | $19.5K |
| May 14, 2026 | Adams Thomas | F | $11.4K |
7 institutional holders with $16.7M total value (2,869,915 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, CHARLES. Net buying activity: 5 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 2,207,698 | $12.8M | 76.9% | — |
| 2 | MORGAN STANLEY | 427,026 | $2.5M | 14.9% | ADD +27.8% |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 120,664 | $701.1K | 4.2% | DOUBLED +829.7% |
| 4 | WELLS FARGO & COMPANY/MN | 47,264 | $274.6K | 1.6% | ADD +78.1% |
| 5 | TWO SIGMA INVESTMENTS, LP | 30,643 | $178.0K | 1.1% | NEW |
| 6 | BANK OF AMERICA CORP /DE/ | 27,926 | $162.3K | 1.0% | DOUBLED +128.2% |
| 7 | FMR LLC | 8,694 | $50.5K | 0.3% | DOUBLED +610.9% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | ADD | 334,217 | 427,026 | +27.8% | $2.5M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 26,544 | 47,264 | +78.1% | $274.6K | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 30,643 | — | $178.0K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 12,238 | 27,926 | +128.2% | $162.3K | 2025-Q4 |
| FMR LLC | DOUBLED | 1,223 | 8,694 | +610.9% | $50.5K | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 104,600 | 0 | -100.0% | $0.00 | 2025-Q3 |
| MORGAN STANLEY | ADD | 193,208 | 299,820 | +55.2% | $1.1M | 2025-Q2 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | DOUBLED | 12,813 | 119,121 | +829.7% | $426.5K | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 204,456 | 104,600 | -48.8% | $374.5K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 1 | 21,951 | +2195000.0% | $78.6K | 2025-Q2 |
| UBS Group AG | DOUBLED | 4,189 | 17,269 | +312.2% | $61.8K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | TRIM | 25,855 | 13,829 | -46.5% | $49.5K | 2025-Q2 |
| FMR LLC | TRIM | 2,544 | 1,053 | -58.6% | $3.8K | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 51,988 | 204,456 | +293.3% | $519.3K | 2025-Q1 |
| MORGAN STANLEY | DOUBLED | 86,308 | 193,208 | +123.9% | $490.7K | 2025-Q1 |
| UBS Group AG | ADD | 2,553 | 4,189 | +64.1% | $10.6K | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 98,100 | 51,988 | -47.0% | $200.2K | 2024-Q4 |
| CITADEL ADVISORS LLC | TRIM | 120,109 | 45,911 | -61.8% | $176.8K | 2024-Q4 |
| UBS Group AG | DOUBLED | 888 | 2,553 | +187.5% | $9.8K | 2024-Q4 |
| MORGAN STANLEY | TRIM | 168,210 | 90,689 | -46.1% | $247.6K | 2024-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 12,813 | — | $35.0K | 2024-Q3 |
11 unique insiders with 5 transactions. Net insider value: $1.5M ($1.5M bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 18, 2026 | Schiller Eric | Chief Technology Officer | BUY | 5,000 | $3.91 | $19.6K |
| May 15, 2026 | Tharby Linda M | Chief Executive Officer | BUY | 1,191 | $3.92 | $4.7K |
| May 15, 2026 | Tharby Linda M | Chief Executive Officer | BUY | 1,191 | $1,191.00 | $1.4M |
| May 14, 2026 | Adams Thomas Edward | Chief Financial Officer | BUY | 5,041 | $3.86 | $19.5K |
| May 14, 2026 | Adams Thomas Edward | Chief Financial Officer | F | 2,900 | $3.94 | $11.4K |
| May 14, 2026 | Adams Thomas Edward | Chief Financial Officer | M | 8,193 | $0.00 | $0.00 |
| May 14, 2026 | Pazdan Christopher | Chief Operating Officer | BUY | 5,000 | $3.88 | $19.4K |
| May 14, 2026 | Pazdan Christopher | Chief Operating Officer | M | 5,327 | $0.00 | $0.00 |
| May 14, 2026 | Pazdan Christopher | Chief Operating Officer | F | 1,470 | $3.94 | $5.8K |
| Apr 1, 2026 | Matin Shahriar | Director | A | 3,472 | $4.32 | $15.0K |
| Apr 1, 2026 | French Donna | Director | A | 3,472 | $4.32 | $15.0K |
| Apr 1, 2026 | WHOLIHAN EDWARD | Director | A | 3,472 | $4.32 | $15.0K |
| Apr 1, 2026 | CASCELLA ROBERT | Director | A | 3,472 | $4.32 | $15.0K |
| Apr 1, 2026 | FLETCHER R JOHN | Director | A | 5,208 | $4.32 | $22.5K |
| Mar 31, 2026 | Manko Joseph M. Jr. | Director | A | 3,472 | $0.00 | $0.00 |
| Mar 31, 2026 | Manko Joseph M. Jr. | Director | A | 3,472 | $0.00 | $0.00 |
| Mar 17, 2026 | KALBERMATTEN ADAM R | President-Chief Commercial Off | A | 45,098 | $0.00 | $0.00 |
| Mar 17, 2026 | KALBERMATTEN ADAM R | President-Chief Commercial Off | A | 67,779 | $0.00 | $0.00 |
| Mar 17, 2026 | Pazdan Christopher | Chief Operating Officer | A | 46,929 | $0.00 | $0.00 |
| Mar 17, 2026 | Pazdan Christopher | Chief Operating Officer | A | 31,226 | $0.00 | $0.00 |
| Mar 17, 2026 | Adams Thomas Edward | Chief Financial Officer | A | 58,490 | $0.00 | $0.00 |
| Mar 17, 2026 | Adams Thomas Edward | Chief Financial Officer | A | 38,918 | $0.00 | $0.00 |
| Mar 17, 2026 | Adams Thomas Edward | Chief Financial Officer | A | 38,918 | $0.00 | $0.00 |
| Mar 17, 2026 | Pazdan Christopher | Chief Operating Officer | A | 31,226 | $0.00 | $0.00 |
| Mar 17, 2026 | KALBERMATTEN ADAM R | President-Chief Commercial Off | A | 45,098 | $0.00 | $0.00 |
| Mar 16, 2026 | Pazdan Christopher | Chief Operating Officer | M | 5,064 | $0.00 | $0.00 |
| Mar 16, 2026 | Adams Thomas Edward | Chief Financial Officer | M | 5,404 | $0.00 | $0.00 |
| Mar 16, 2026 | Tharby Linda M | Chief Executive Officer | F | 5,756 | $4.28 | $24.6K |
| Mar 16, 2026 | Tharby Linda M | Chief Executive Officer | M | 15,968 | $0.00 | $0.00 |
| Mar 16, 2026 | Adams Thomas Edward | Chief Financial Officer | F | 2,123 | $4.28 | $9.1K |
| Mar 16, 2026 | Pazdan Christopher | Chief Operating Officer | F | 1,628 | $4.28 | $7.0K |
| Feb 13, 2026 | Manko Joseph M. Jr. | Director | J | 770,418 | $0.00 | $0.00 |
5 SEC filing reports analyzed. Sentiment: 3 bullish, 0 bearish, 1 mixed, 1 neutral. Avg impact: 5.6/10.
BULLISH
CLUSTER
7/10
KORU Medical Systems insiders executed a concentrated buying cluster, with CEO Linda Tharby making a
May 20, 2026
BULLISH
CLUSTER
7/10
Three senior insiders at KORU Medical Systems — CEO, CFO, and COO — collectively purchased ~$1.46M o
May 20, 2026
BULLISH
CLUSTER
7/10
CEO Linda Tharby made a $1.42M open-market purchase, the largest insider buy in the cluster, represe
May 20, 2026
NEUTRAL
CLUSTER
2/10
CFO Thomas Edward Adams and COO Christopher Pazdan made small open-market purchases of KRMD stock on
May 18, 2026
MIXED
8-K
5/10
KORU Medical reported Q1 2026 revenue of $11.8M (+22% YoY), beating the implied run rate from FY gui
May 6, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (82% buy). Based on 11 analysts: 2 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$6.80 mean target
+63.9% upside
Strong Buy (1.40)
$5.00 Low
$8.00 High
| Metric | Value |
|---|---|
| Current Price | $4.15 |
| Target Low | $5.00 |
| Target Mean | $6.80 |
| Target Median | $7.00 |
| Target High | $8.00 |
| # Analysts | 5 |
| Recommendation | Strong Buy (1.40) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.01 | $-0.01 | $0.00 | -150.0% | — | — | $0.0B | 14.0% | 2 |
| Next Q 2026-09-30 |
$0.01 | $0.00 | $0.01 | 0.0% | -50.0% | 0↑ 1↓ | $0.0B | 18.1% | 2 |
| Current FY 2026-12-31 |
$0.02 | $0.01 | $0.03 | 100.0% | -33.3% | — | $0.0B | 18.4% | 2 |
| Next FY 2027-12-31 |
$0.08 | $0.07 | $0.09 | 300.0% | -5.9% | 1↑ 1↓ | $0.1B | 17.0% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.005 | |
| 7d ago | $0.000 | -0.005 |
| 30d ago | $0.000 | -0.005 |
| 60d ago | $0.003 | -0.007 |
| 90d ago | $0.003 | -0.007 |
3 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 13, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Mar 13, 2026 | B. Riley Securities | MAINTAIN | Buy | Buy |
| Dec 22, 2025 | Lake Street | MAINTAIN | Buy | Buy |
| Dec 17, 2025 | Canaccord Genuity | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% | |
| Apr 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% | |
| Mar 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% | |
| Feb 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% | |
| Jan 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 6, 2026
earnings_calendar
KRMD Q1 2026 Earnings After Market Close — 2026-05-06
Mar 12, 2026
earnings_calendar
KRMD Q4 2025 Earnings After Market Close — 2026-03-12
Mar 4, 2026
earnings_calendar
KRMD Q4 2025 Earnings After Market Close — 2026-03-04